Clinical White papers

Database Comparison enables a user to compare a PET or SPECT brain scan of a patient to a database of brain images of the same radiotracer composed of scans from confirmed normal individuals. Learn how Database Comparison supports such analysis for a variety of tracers, providing robust computational algorithms to automate necessary preparation of images.

By Rachid Fahmi, PhD and Guenther Platsch, MD

syngo.via Database Comparison in MI Neurology

07/23/2021

By Munir Ghesani, MD, FACNM, FACR, New York, NY, USA.

The value of PET/CT for melanoma

04/03/2019

PET/CT plays an increasingly important role in the appropriate clinical setting in both initial and subsequent treatment strategies in melanoma management. Read the white paper to discover the value PET/CT imaging can have for melanoma.

By Partha Ghosh, MD, Siemens Healthineers

xSPECT Bone: a clinical overview

05/01/2018

Skeletal scintigraphy has been a mainstay of nuclear medicine for decades. Take a closer look at clinical examples that illustrate the image quality levels in bone scintigraphy made possible using xSPECT Bone™ technology in this SPECT/CT clinical white paper.

By A. Hans Vija, PhD; Carl von Gall, MD; and Partha Ghosh, MD, Siemens Healthineers

Accurate, reproducible, and standardized quantification

01/02/2018

The introduction of xSPECT Quant™ for absolute quantification of ¹⁷⁷Lu, ¹¹¹In, and ¹²³I is a major step toward implementation and expansion of standardized evidence-based medicine in the realm of radionuclide imaging. Download the white paper to learn more about Siemens Healthineers’ xSPECT Quant technology.

By Jackson Kiser, MD, Molecular Imaging and Therapy Consultants of Virginia

Transitioning from mobile to fixed PET/CT services

04/20/2016

Discover how transitioning from a mobile PET scanner—an ideal way to introduce technology to facilities interested in exploring the potential for PET imaging— to a fixed scanner can benefit in a hospital setting.

By Partha Ghosh, MD, Siemens Healthineers; and Dimitre Hristov, PhD, Department of Radiation Oncology, Stanford University

Current role of PET/CT in evaluation of lung cancer

10/01/2015

Learn how PET/CT provides metabolic and morphological information, which has a major impact on the evaluation and therapy planning of primary and recurrent lung tumors.

FDG PET/CT and cervical cancer

PET/CT is a powerful modality used to assess cervical cancer, particularly in tumors of stage IB and beyond. As the topic of cervical cancer and PET/CT has been increasing in interest in the last years, stay informed on the status of the disease, guidelines, and reimbursement opportunities by reading the following white paper.

FDG PET/CT and breast cancer

PET/CT plays an increasing role in breast cancer staging, treatment, and follow-up. Discover how new technical developments in PET scanner technologies might additional contribute to strengthening and expanding the role of clinical PET/CT in breast cancer care.

The PET/CT imaging center as service provider to their clinical partners

Uncover how to ensure optimal patient management and learn how the relationship between the imaging and referring physician can help to ensure optimal patient management and benefit patients by having a more personal interaction before and after a PET/CT exam.

NaF PET/CT in prostate cancer

Explore the role of PET/CT in imaging high-risk patients (such as those with an elevated PSA level or Gleason score) for skeletal metastases. Read the white paper to review PET's role on therapy decisions during initial diagnosis and therapy monitoring.